Exane Asset Management Qiagen N.V. Transaction History

Exane Asset Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$45.29 - $50.76 $16.4 Million - $18.4 Million	361,663 New	361,663 $16.6 Million
Q4 2019 Feb 03, 2020	SELL	$25.41 - $43.1 $7.17 Million - $12.2 Million	-282,203 Closed	0 $0
Q3 2019 Oct 24, 2019	SELL	$32.73 - $40.81 $966,222 - $1.2 Million	-29,521 Reduced 9.47%	282,203 $9.3 Million
Q2 2019 Aug 05, 2019	BUY	$35.73 - $41.39 $11.1 Million - $12.9 Million	311,724 New	311,724 $0
Q4 2018 Feb 05, 2019	SELL	$32.65 - $37.95 $17 Million - $19.8 Million	-522,037 Closed	0 $0
Q3 2018 Nov 16, 2018	SELL	$35.99 - $39.39 $8.63 Million - $9.45 Million	-239,850 Reduced 31.48%	522,037 $0
Q2 2018 Sep 06, 2018	BUY	$31.23 - $37.47 $3.46 Million - $4.15 Million	110,651 Added 16.99%	761,887 $0
Q1 2018 Apr 30, 2018	SELL	$31.01 - $34.72 $6.45 Million - $7.22 Million	-207,972 Reduced 24.21%	651,236 $0
Q4 2017 Feb 08, 2018	SELL	$30.68 - $35.37 $10.1 Million - $11.6 Million	-328,060 Reduced 27.63%	859,208 $0
Q3 2017 Oct 13, 2017	BUY	$31.02 - $32.94 $36.8 Million - $39.1 Million	1,187,268	1,187,268 $37.4 Billion

6.34M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.92B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

Stay updated on Exane Asset Management with notifications on news.